ProCE Banner Activity

Personalized Care for Mild to Moderate Atopic Dermatitis: The Importance of Timely Diagnosis 

Clinical Thought

A key step in developing initial treatment plans for patients with AD is determining an accurate diagnosis of disease severity, which can present differently across the range of skin tones. Learn about nonsteroidal topical therapy options for mild to moderate AD, and why treatment should be personalized for patients to achieve disease control and improve quality of life.

Released: May 20, 2025

Expiration: May 19, 2026

Share

Provided by

Provided by Clinical Care Options in partnership with Practicing Clinicians Exchange

ProCE Banner

Supporters

Supported by an educational grant from Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc

Partners

Practicing Clinicians Exchange, LLC

ProCE Banner

Disclosure

Primary Author

Benjamin Ungar, MD: consultant/advisor/speaker: AbbVie, Botanix, Bristol Myers Squibb, Fresenius Kabi, Galderma, Johnson & Johnson, Leo, Lilly, Pfizer, Primus, Sanofi, UCB; researcher (paid to institution): Incyte, Rapt, Sanofi.